Related Experiment Video
Updated: Sep 6, 2025

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
[Influence of smoking on the gastrointestinal tract : Range of findings]
Sabine Popp1, Thomas Mang2, Martina Scharitzer3
1Universitätsklinik für Radiologie und Nuklearmedizin, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090, Wien, Österreich.
Background:
Nicotine is a highly addictive drug that, if consumed regularly, can result in chronic or incurable diseases and a reduced quality of life.
Objectives:
The aim of this review is to describe the possible health consequences of smoking on the gastrointestinal tract and to provide an overview of related neoplastic and nonneoplastic gastrointestinal diseases.
Materials And Methods:
Based on an extensive literature review, the current knowledge about smoker-associated diseases of the gastrointestinal tract is summarized.
Results:
Smoking is a significant risk factor for the development of neoplastic and nonneoplastic diseases within the entire gastrointestinal tract. However, they are not associated with specific, smoking-associated radiologic imaging features.
Conclusion:
Knowledge of a smoker's history and possible consequences of nicotine on the gastrointestinal tract can help in the interpretation of radiological images and improve diagnostic decision-making skills and accuracy.
Related Concept Videos
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Other Disorders of Digestive System
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Stress Prevention and Stress Management Techniques IV
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...

